Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Nina Glaser"'
Autor:
Nina Glaser, Markus Reiher
Publikováno v:
CHIMIA, Vol 78, Iss 4 (2024)
Many complex chemical problems encoded in terms of physics-based models become computationallyintractable for traditional numerical approaches due to their unfavorable scaling with increasing molecular size. Tensor decomposition techniques can overco
Externí odkaz:
https://doaj.org/article/c0c43ccdc5eb4a7db337f7386e75f9f1
Autor:
Andreas Blum, Dieter Dorsch, Nina Linde, Susanne Brandstetter, Hans-Peter Buchstaller, Michael Busch, Nina Glaser, Ulrich Grädler, Aaron Ruff, Carl Petersson, Hanno Schieferstein, Eva Sherbetjian, Christina Esdar
Publikováno v:
Journal of Medicinal Chemistry. 66:2386-2395
Autor:
Sven Jaeckel, Annika Hansen, Nina Glaser, Sigrid Johannes, Willem Sloot, Valentina Lai, Juergen Hellmann, Anja Knippel, Manuela Onidi
Publikováno v:
Toxicology and applied pharmacology. 429
M3258 is the first selective inhibitor of the immunoproteasome subunit LMP7 (Large multifunctional protease 7) in early clinical development with the potential to improve therapeutic utility in patients of multiple myeloma (MM) or other hematological
Publikováno v:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 62:1346-1353
Chemische Stoffe und Produkte fuhren jedes Jahr zu einer Vielzahl von Vergiftungen oder Verdachtsfallen von Vergiftungen. Die Giftinformationszentren (GIZ) beraten dazu Laien und medizinisches Personal und dokumentieren die Anfragen in ihren Datenban
Autor:
Nina Glaser, Gerhard König, Benjamin Schroeder, Alžbeta Kubincová, Sereina Riniker, Philippe H. Hünenberger
Publikováno v:
Journal of Chemical Information and Modeling, 60 (11)
König, G, Glaser, N, Schroeder, B, Kubincová, A, Hünenberger, P H & Riniker, S 2020, ' An alternative to conventional λ-intermediate states in alchemical free energy calculations : λ-enveloping distribution sampling ', Journal of Chemical Information and Modeling, vol. 60, no. 11, pp. 5407-5423 . https://doi.org/10.1021/acs.jcim.0c00520
König, G, Glaser, N, Schroeder, B, Kubincová, A, Hünenberger, P H & Riniker, S 2020, ' An alternative to conventional λ-intermediate states in alchemical free energy calculations : λ-enveloping distribution sampling ', Journal of Chemical Information and Modeling, vol. 60, no. 11, pp. 5407-5423 . https://doi.org/10.1021/acs.jcim.0c00520
Alchemical free energy calculations typically rely on intermediate states to bridge between the relevant phase spaces of the two end states. These intermediate states are usually created by mixing the energies or parameters of the end states accordin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65d4bfe6e35d03f429673512e8e6b2b1
https://hdl.handle.net/20.500.11850/454502
https://hdl.handle.net/20.500.11850/454502
Autor:
Mohammad Abdollahi, F.F. Albaqami, K.M. Alharthy, H.N. Althurwi, P. Apalaki, Monica G. Arana-Puse, Asnida Arifin, Leonello Attias, Marek Banasik, Irene M. Baskerville-Abraham, Yasna Behmanesh, Yedidia Bentur, Tarryn Lee Botha, Aleksandra Buha Đorđević, Félix Carvalho, Fanny L. Casado, Kok Meng Chan, Tsun-Jen Cheng, Jang-Sik Choi, Cristiana L. Correa, Erdem Coskun, Vincent Danel, Yuri Bruinen de Bruin, Maurella Della Seta, Ana del Peso, Luz María Del Razo, Herbert Desel, John H. Duffus, Danijela Đukić-Ćosić, Jean-Christophe Gallart, Susana I. García, Nina Glaser, Choo Ta Goh, Maria E. Gonsebatt, Xinsheng Gu, Mary Gulumian, Adriana I. Haas, Homero C. Harari, Raul E. Harari, Carole Hirn, Lisa Hoffman, M. Hornychová, Toshime Igarashi, Salmaan Hussain Inayat-Hussain, Maryam Zare Jeddi, Carolina Juanena, Jahangir Kamaldin, Harriet Kamendi, Kh. Kh. Khamidulina, Shabnam Kharabaf, Jongwoon Kim, Lisbeth E. Knudsen, Kannan Krishnan, Jens Küllmer, B.A. Kurlyandskiy, Amalia Laborde, Birgitte Lindeman, Carlo Alessandro Locatelli, Ramiro I. Lopez, Sara Maisanaba, Stefan Mandić-Rajčević, Ida Marcello, Marina Marinovich, Vesna Matović, Asish Mohapatra, Diana Montenegro, Takeshi Morita, Marek Murias, Suresh K. Nagumalli, Alba Negrin, Shekoufeh Nikfar, Monica Nordberg, Magali Oliva-Labadie, Eren Ozcagli, R. Ponampalam, Pamela Prud’homme, Emmanuel Puskarczyk, Noor Amalina Ramle, Fernando Remião, Guillermo Repetto, Manuel Repetto, Juan Carlos Rios, Arisleida J. Rodríguez, Maritza Rojas, Raquel Rojas, Maristella Rubbiani, Jaana Rysä, Mazrura Sahani, Ulrich Schlottmann, Giuliana F.R. Selmi, Yoshiyuki Shigeta, Hyun Kil Shin, K.K. Sidorov, Lorena Silva, Jorge Soares, Sandra Solari, Todd Stedeford, Douglas M. Templeton, A.M. Tsatsakis, E. Vakonaki, Jan van der Kolk, Maylin E. Velásquez, J. Veselá, Edda C. Villaamil Lepori, Matti Viluksela, M. Vysloužilová, Jung-Der Wang, Victor Wepener, Philip Wexler, Lars Wiklund, Paul F.A. Wright, Chen-Chang Yang, Seokjoo Yoon, Tae Hyun Yoon, Flavio A.D. Zambrone, Joseph Zayed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36280e0b048ad74949094561105c5a21
https://doi.org/10.1016/b978-0-12-821611-8.00053-x
https://doi.org/10.1016/b978-0-12-821611-8.00053-x
Autor:
Dieter Dorsch, Nina Glaser, Eva Sherbetjian, Ulrich Graedler, Andreas Blum, Michael Busch, Nina Linde, Carl Petersson, Christina Esdar, Aaron Ruff
Publikováno v:
Cancer Research. 81:1482-1482
Oncogenic mutations in cKIT in exons 9 and 11 are the main driver of gastrointestinal stromal tumors (GIST). Imatinib is standard of care in 1L in unresectable metastatic or recurrent GIST, yet secondary resistance mutations in exons 13/14 and 17/18
Autor:
Anna Gardberg, Federica Morandi, Katherine Roe, Carolyn Wing, Andreas Goutopoulos, Richard D. Caldwell, Johnson Theresa L, Yi-Ying Chen, Constantin Neagu, Shashank Kulkarni, Ralf Schmidt, Roland Grenningloh, Sherer Brian A, Sven Poetzsch, Andrew Bender, Anja Goettsche, Nina Glaser, Christopher Charles Victor Jones, Xiaohua Zhu, Zahid Ali, Jared Head, Zhizhou Fang, Christine Maurer, Ariele Viacava Follis, Potnick Justin, Reinaldo Jones, Hui Qiu, Bettina Hanschke
Publikováno v:
Bioorganic & Medicinal Chemistry. 40:116163
Bruton’s tyrosine kinase (BTK) is a cytoplasmic, non-receptor tyrosine kinase member of the TEC family of tyrosine kinases. Pre-clinical and clinical data have shown that targeting BTK can be used for the treatment for B-cell disorders. Here we dis